Solu is combating antibiotic resistance by building the most extensive bacterial DNA library
Solu has raised $1.1M in total funding. The most recent round was Pre-Seed. The last funding was announced in June 2023.
Solu's investors include Lifeline Ventures, Wave Ventures, Kristian Ranta.
Solu is headquartered in Helsinki, Finland.
Solu is combating antibiotic resistance by building the most extensive bacterial DNA library
Solu is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Solu — Funding & Investors." VCBacked, June 15, 2023, https://www.vcbacked.co/company/solu-helsinki. Accessed October 21, 2026.
VCBacked. (2023). Solu — Funding & Investors. Retrieved October 21, 2026, from https://www.vcbacked.co/company/solu-helsinki
{{cite web |title=Solu — Funding & Investors |url=https://www.vcbacked.co/company/solu-helsinki |website=VCBacked |access-date=October 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated